![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PROS1 |
Gene summary for PROS1 |
![]() |
Gene information | Species | Human | Gene symbol | PROS1 | Gene ID | 5627 |
Gene name | protein S | |
Gene Alias | PROS | |
Cytomap | 3q11.1 | |
Gene Type | protein-coding | GO ID | GO:0006508 | UniProtAcc | A0A0S2Z4K3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5627 | PROS1 | NAFLD1 | Human | Liver | NAFLD | 3.26e-10 | 1.06e+00 | -0.04 |
5627 | PROS1 | S43 | Human | Liver | Cirrhotic | 5.33e-10 | 5.26e-02 | -0.0187 |
5627 | PROS1 | HCC1_Meng | Human | Liver | HCC | 1.71e-81 | 4.33e-01 | 0.0246 |
5627 | PROS1 | HCC2_Meng | Human | Liver | HCC | 1.86e-15 | -2.56e-01 | 0.0107 |
5627 | PROS1 | cirrhotic1 | Human | Liver | Cirrhotic | 1.01e-05 | -2.28e-01 | 0.0202 |
5627 | PROS1 | cirrhotic2 | Human | Liver | Cirrhotic | 1.18e-05 | -9.85e-02 | 0.0201 |
5627 | PROS1 | HCC1 | Human | Liver | HCC | 2.39e-04 | 4.11e+00 | 0.5336 |
5627 | PROS1 | HCC2 | Human | Liver | HCC | 8.30e-06 | 3.81e+00 | 0.5341 |
5627 | PROS1 | Pt13.b | Human | Liver | HCC | 2.05e-06 | -6.83e-02 | 0.0251 |
5627 | PROS1 | S015 | Human | Liver | HCC | 2.60e-02 | 6.44e-01 | 0.2375 |
5627 | PROS1 | S028 | Human | Liver | HCC | 2.63e-18 | 1.11e+00 | 0.2503 |
5627 | PROS1 | S029 | Human | Liver | HCC | 5.67e-19 | 1.27e+00 | 0.2581 |
5627 | PROS1 | male-WTA | Human | Thyroid | PTC | 5.36e-55 | 6.86e-01 | 0.1037 |
5627 | PROS1 | female-WTA | Human | Thyroid | PTC | 6.34e-05 | 3.26e-01 | 0.0726 |
5627 | PROS1 | PTC01 | Human | Thyroid | PTC | 4.98e-54 | 1.03e+00 | 0.1899 |
5627 | PROS1 | PTC03 | Human | Thyroid | PTC | 5.01e-06 | 3.98e-01 | 0.1784 |
5627 | PROS1 | PTC04 | Human | Thyroid | PTC | 4.37e-34 | 8.26e-01 | 0.1927 |
5627 | PROS1 | PTC05 | Human | Thyroid | PTC | 3.20e-58 | 2.47e+00 | 0.2065 |
5627 | PROS1 | PTC06 | Human | Thyroid | PTC | 1.21e-89 | 2.19e+00 | 0.2057 |
5627 | PROS1 | PTC07 | Human | Thyroid | PTC | 1.65e-119 | 2.03e+00 | 0.2044 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000759911 | Liver | Cirrhotic | hemostasis | 80/4634 | 222/18723 | 1.08e-04 | 1.10e-03 | 80 |
GO:005081711 | Liver | Cirrhotic | coagulation | 79/4634 | 222/18723 | 1.90e-04 | 1.76e-03 | 79 |
GO:00610451 | Liver | Cirrhotic | negative regulation of wound healing | 31/4634 | 78/18723 | 2.43e-03 | 1.46e-02 | 31 |
GO:005087812 | Liver | Cirrhotic | regulation of body fluid levels | 118/4634 | 379/18723 | 2.65e-03 | 1.55e-02 | 118 |
GO:19030351 | Liver | Cirrhotic | negative regulation of response to wounding | 34/4634 | 94/18723 | 8.84e-03 | 4.08e-02 | 34 |
GO:005254722 | Liver | HCC | regulation of peptidase activity | 247/7958 | 461/18723 | 8.28e-07 | 1.27e-05 | 247 |
GO:005254822 | Liver | HCC | regulation of endopeptidase activity | 230/7958 | 432/18723 | 3.58e-06 | 4.68e-05 | 230 |
GO:00301932 | Liver | HCC | regulation of blood coagulation | 46/7958 | 66/18723 | 7.12e-06 | 8.47e-05 | 46 |
GO:19000462 | Liver | HCC | regulation of hemostasis | 46/7958 | 68/18723 | 2.43e-05 | 2.56e-04 | 46 |
GO:004586122 | Liver | HCC | negative regulation of proteolysis | 186/7958 | 351/18723 | 4.19e-05 | 4.11e-04 | 186 |
GO:00508182 | Liver | HCC | regulation of coagulation | 47/7958 | 71/18723 | 4.68e-05 | 4.50e-04 | 47 |
GO:004206022 | Liver | HCC | wound healing | 219/7958 | 422/18723 | 5.34e-05 | 5.04e-04 | 219 |
GO:006104122 | Liver | HCC | regulation of wound healing | 78/7958 | 134/18723 | 1.73e-04 | 1.36e-03 | 78 |
GO:190303421 | Liver | HCC | regulation of response to wounding | 94/7958 | 167/18723 | 2.19e-04 | 1.66e-03 | 94 |
GO:005134622 | Liver | HCC | negative regulation of hydrolase activity | 195/7958 | 379/18723 | 2.44e-04 | 1.82e-03 | 195 |
GO:00075962 | Liver | HCC | blood coagulation | 118/7958 | 217/18723 | 2.63e-04 | 1.94e-03 | 118 |
GO:00301952 | Liver | HCC | negative regulation of blood coagulation | 33/7958 | 49/18723 | 3.86e-04 | 2.62e-03 | 33 |
GO:00075992 | Liver | HCC | hemostasis | 119/7958 | 222/18723 | 5.25e-04 | 3.41e-03 | 119 |
GO:19000472 | Liver | HCC | negative regulation of hemostasis | 33/7958 | 50/18723 | 6.74e-04 | 4.15e-03 | 33 |
GO:00508172 | Liver | HCC | coagulation | 118/7958 | 222/18723 | 8.41e-04 | 5.03e-03 | 118 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04610 | Liver | NAFLD | Complement and coagulation cascades | 35/1043 | 86/8465 | 2.48e-11 | 2.04e-09 | 1.64e-09 | 35 |
hsa046101 | Liver | NAFLD | Complement and coagulation cascades | 35/1043 | 86/8465 | 2.48e-11 | 2.04e-09 | 1.64e-09 | 35 |
hsa046102 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa046103 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa046104 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
hsa046105 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
PROS1 | AXL | PROS1_AXL | PROS | Breast | ADJ |
PROS1 | AXL | PROS1_AXL | PROS | Breast | DCIS |
PROS1 | AXL | PROS1_AXL | PROS | Breast | Healthy |
PROS1 | AXL | PROS1_AXL | PROS | Cervix | ADJ |
PROS1 | AXL | PROS1_AXL | PROS | Cervix | CC |
PROS1 | AXL | PROS1_AXL | PROS | Cervix | Healthy |
PROS1 | AXL | PROS1_AXL | PROS | Endometrium | ADJ |
PROS1 | AXL | PROS1_AXL | PROS | Endometrium | AEH |
PROS1 | AXL | PROS1_AXL | PROS | Esophagus | ESCC |
PROS1 | AXL | PROS1_AXL | PROS | GC | ADJ |
PROS1 | AXL | PROS1_AXL | PROS | HNSCC | Healthy |
PROS1 | AXL | PROS1_AXL | PROS | HNSCC | OSCC |
PROS1 | AXL | PROS1_AXL | PROS | HNSCC | Precancer |
PROS1 | AXL | PROS1_AXL | PROS | Liver | HCC |
PROS1 | AXL | PROS1_AXL | PROS | Liver | Healthy |
PROS1 | AXL | PROS1_AXL | PROS | Liver | Precancer |
PROS1 | AXL | PROS1_AXL | PROS | Lung | AAH |
PROS1 | AXL | PROS1_AXL | PROS | Lung | ADJ |
PROS1 | AXL | PROS1_AXL | PROS | Lung | AIS |
PROS1 | AXL | PROS1_AXL | PROS | Lung | IAC |
Page: 1 2 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PROS1 | SNV | Missense_Mutation | novel | c.646N>A | p.Val216Met | p.V216M | P07225 | protein_coding | tolerated(0.22) | possibly_damaging(0.546) | TCGA-A2-A3XS-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cytoxan | PD |
PROS1 | SNV | Missense_Mutation | novel | c.778N>A | p.Pro260Thr | p.P260T | P07225 | protein_coding | deleterious(0.02) | possibly_damaging(0.749) | TCGA-AC-A2BK-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | cytoxan | CR |
PROS1 | SNV | Missense_Mutation | novel | c.1226N>C | p.Lys409Thr | p.K409T | P07225 | protein_coding | tolerated(0.31) | benign(0.422) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PROS1 | SNV | Missense_Mutation | rs387906674 | c.1063C>T | p.Arg355Cys | p.R355C | P07225 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AO-A0JC-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | fluorouracil | SD |
PROS1 | SNV | Missense_Mutation | c.832N>C | p.Asp278His | p.D278H | P07225 | protein_coding | deleterious(0) | probably_damaging(0.927) | TCGA-BH-A18I-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
PROS1 | SNV | Missense_Mutation | c.308N>T | p.Ser103Leu | p.S103L | P07225 | protein_coding | tolerated(0.07) | probably_damaging(0.987) | TCGA-C8-A12Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
PROS1 | SNV | Missense_Mutation | novel | c.25N>A | p.Gly9Arg | p.G9R | P07225 | protein_coding | tolerated_low_confidence(0.44) | benign(0) | TCGA-C8-A8HP-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | 5-fluorouracil | CR |
PROS1 | SNV | Missense_Mutation | novel | c.514N>T | p.Ser172Cys | p.S172C | P07225 | protein_coding | deleterious(0) | possibly_damaging(0.841) | TCGA-E9-A1ND-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | aromasin | SD |
PROS1 | insertion | Frame_Shift_Ins | novel | c.1697_1698insATTAGGTTGGATAGGTGGGGAAA | p.Ser566ArgfsTer35 | p.S566Rfs*35 | P07225 | protein_coding | TCGA-A8-A07G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | CR | ||
PROS1 | insertion | Frame_Shift_Ins | novel | c.20_21insA | p.Cys8LeufsTer31 | p.C8Lfs*31 | P07225 | protein_coding | TCGA-AC-A3QQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5627 | PROS1 | DRUGGABLE GENOME | Warfarin | WARFARIN | ||
5627 | PROS1 | DRUGGABLE GENOME | Lusutrombopag | LUSUTROMBOPAG | ||
5627 | PROS1 | DRUGGABLE GENOME | avatrombopag | AVATROMBOPAG | ||
5627 | PROS1 | DRUGGABLE GENOME | Avatrombopag | AVATROMBOPAG | ||
5627 | PROS1 | DRUGGABLE GENOME | ethinyl estradiol / norelgestromin | |||
5627 | PROS1 | DRUGGABLE GENOME | MENADIONE | MENADIONE | ||
5627 | PROS1 | DRUGGABLE GENOME | Estradiol | ESTRADIOL | ||
5627 | PROS1 | DRUGGABLE GENOME | estradiol / progesterone | |||
5627 | PROS1 | DRUGGABLE GENOME | lusutrombopag | LUSUTROMBOPAG | ||
5627 | PROS1 | DRUGGABLE GENOME | warfarin | WARFARIN |
Page: 1 2 |